JMT101 and kinase inhibitor in advanced NSCLC with EGFR exon 20 insertion
| Title | JMT101 and kinase inhibitor in advanced NSCLC with EGFR exon 20 insertion |
|---|---|
| Description | Dual targeting EGFR exon 20 insertion with a monoclonal antibody (JMT101) and kinase inhibitor in advanced non-small-cell lung cancer: activity, safety and biomarker analysis from a phase 1b trial |
| Organism | Homo |
| Data Type | Clinical Research data |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA010856 |
| Release Date | 2022-09-06 |
| Submitter | Li Zhang (zhangli@sysucc.org.cn) |
| Organization | Sun Yat-sen University Cancer Center |
| Submission Date | 2022-09-05 |
HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download Times | Download |
|---|---|---|---|---|---|---|---|
| OMIX001773-01 | JMT101_CSP_001_7507_20220901_011100 | 57 | Clinical Research data | 14.2 MB | zip | 0 | Controlled |